Gastroesophageal Reflux Disease

Showing 1 - 25 of 241

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastroesophageal Reflux Disease Trial (endoloop mediated cardioplication (ECLC) procedure)

Not yet recruiting
  • Gastroesophageal Reflux Disease
  • endoloop mediated cardioplication (ECLC) procedure
  • (no location specified)
Nov 22, 2023

Gastroesophageal Reflux Disease Trial (Antireflux mucosal ablation, Sham procedure)

Not yet recruiting
  • Gastroesophageal Reflux Disease
  • Antireflux mucosal ablation
  • Sham procedure
  • (no location specified)
Oct 26, 2023

Gastroesophageal Reflux Disease Trial (Vonoprazan)

Not yet recruiting
  • Gastroesophageal Reflux Disease
  • (no location specified)
Oct 24, 2023

Gastroesophageal Reflux Disease Trial in Assiut (Nursing Teaching)

Not yet recruiting
  • Gastroesophageal Reflux Disease
  • Nursing Teaching
  • Assiut, Egypt
    Faculty of Nursing Assiut University
Jul 10, 2023

Study to Evaluate the Efficacy and Safety of FEXUCLUE Tablet

Recruiting
  • Gastroesophageal Reflux Disease
  • Fexuprazan Hydrochloride
  • Busan, Korea, Republic of
    Co&Ping Otolaryngology Clinic
May 24, 2023

Gastroesophageal Reflux Disease, Obesity, Morbid Trial in Istanbul (laparoscopic sleeve gastrectomy)

Completed
  • Gastroesophageal Reflux Disease
  • Obesity, Morbid
  • laparoscopic sleeve gastrectomy
  • Istanbul, Turkey
    Fatih sultan mehmet training and research hospital
Jan 31, 2023

Gastroesophageal Reflux Disease Trial in Seoul (Tegoprazan, Esomeprazole)

Not yet recruiting
  • Gastroesophageal Reflux Disease
  • Seoul, Korea, Republic of
    Severance Hospital
Jan 18, 2023

After Medical and Surgical Treatment of Gastroesophageal Reflux

Active, not recruiting
  • Gastroesophageal Reflux Disease
  • Questionnaires to evaluate QOL
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Department of Cardiothoracic Surgery
Jan 23, 2023

A Multi-Center, Prospective, Observational Study to Evaluate

Recruiting
  • Gastroesophageal Reflux Disease
  • Fexuprazan Hydrochloride
  • Busan, Korea, Republic of
    Kosin University Gospel Hospital
Dec 13, 2022

Gastroesophageal Reflux Disease Trial in Lviv (Laparoscopic fundoplication)

Completed
  • Gastroesophageal Reflux Disease
  • Laparoscopic fundoplication
  • Lviv, Ukraine
    Danylo Halytsky Lviv National Medical University
Dec 10, 2022

Improvement Effect on Subjective Symptom of FEXUCLUE Tab

Recruiting
  • Gastroesophageal Reflux Disease
  • Jeonju, Korea, Republic of
    Jeonbuk National University Hospital
Nov 14, 2022

Gastroesophageal Reflux Disease Trial in Worldwide (IV pantoprazole)

Recruiting
  • Gastroesophageal Reflux Disease
  • IV pantoprazole
  • Dallas, Texas
  • +18 more
Nov 8, 2022

Abdominal Pain, Barrett Esophagus, Gastroesophageal Reflux Disease Trial in Philadelphia (Esophagogastroduodenoscopy,

Recruiting
  • Barrett Esophagus
  • Gastroesophageal Reflux Disease
  • Biopsy
  • +4 more
  • Philadelphia, Pennsylvania
  • +1 more
Oct 27, 2022

Proximal Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Reflux Disease Trial in Nanchong (Proximal Gastrectomy

Recruiting
  • Proximal Gastric Adenocarcinoma
  • +2 more
  • Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty
  • Nanchong, Sichuan, China
    Yunhong Tian
Aug 23, 2022

GERD, Gastroesophageal Reflux Disease Trial in United States (LINX device)

Completed
  • GERD
  • Gastroesophageal Reflux Disease
  • LINX device
  • Tucson, Arizona
  • +11 more
Aug 8, 2022

Gastroesophageal Reflux Disease, GERD, Gastroesophageal Erosion Trial in Moscow (diet adherence, No diet adherence, Change in

Recruiting
  • Gastroesophageal Reflux Disease
  • +5 more
  • diet adherence
  • +5 more
  • Moscow, Russian Federation
    Federal State Budgetary Scientific Institution "Federal Research
Aug 1, 2022

Gastroesophageal Reflux Disease Trial in Mexico City (Ablation of the gastroesophageal junction with hybrid argon plasma,

Recruiting
  • Gastroesophageal Reflux Disease
  • Ablation of the gastroesophageal junction with hybrid argon plasma
  • mucosectomy with band of the gastroesophageal junction
  • Mexico City, Mexico
    Centro Medico Nacional Siglo XXI Hospital de Especialidades
Jul 21, 2022

Gastroesophageal Reflux Disease Trial in Seoul (AD-214, AD-2141)

Completed
  • Gastroesophageal Reflux Disease
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jul 19, 2022

Gastroesophageal Reflux Disease, Excessive Weight Loss, Total Weight Loss Trial in Beijing (reestablishment of the acute angle

Recruiting
  • Gastroesophageal Reflux Disease
  • +4 more
  • reestablishment of the acute angle of His
  • sleeve gastrectomy
  • Beijing, Beijing, China
    Beijing Chaoyang Hospital
Jul 6, 2022

Gastroesophageal Reflux Disease, Endoscopy Trial (Anti-Reflux Mucosectomy, Anti-reflux mucosal ablation)

Not yet recruiting
  • Gastroesophageal Reflux Disease
  • Endoscopy
  • Anti-Reflux Mucosectomy
  • Anti-reflux mucosal ablation
  • (no location specified)
Jun 13, 2022

Gastroesophageal Reflux Disease Trial in Gieres (Z0063, Gaviscon)

Completed
  • Gastroesophageal Reflux Disease
  • Gieres, France
    Investigational Site Number 2500001
May 11, 2022

Transoral Fundoplication Prior to Sleeve Gastrectomy Versus RNY

Active, not recruiting
  • Gastroesophageal Reflux Disease
  • Transoral Fundoplication and Sleeve Gastrectomy
  • Gastric Bypass
  • West Columbia, South Carolina
    Lexington Health Incorporated
May 3, 2022

Gastroesophageal Reflux Disease Trial in Merthyr Tydfil (Z0063, Gaviscon)

Completed
  • Gastroesophageal Reflux Disease
  • Merthyr Tydfil, United Kingdom
    Investigational site 826001
Apr 21, 2022

Gastroesophageal Reflux Disease Trial in Roma, Timisoara (Marial® + PPI (generic omeprazole), PPI alone (generic omeprazole))

Recruiting
  • Gastroesophageal Reflux Disease
  • Marial® + PPI (generic omeprazole)
  • PPI alone (generic omeprazole)
  • Roma, Italy
  • +1 more
Mar 15, 2022

Airway Disease, Barrett's and Underdiagnosed Reflux

Not yet recruiting
  • Airway Disease
  • +2 more
    • New York, New York
      NYU Clinical & Translational Science Institute Clinical Research
    Jan 18, 2022